PDZ-mediated signaling through syndecan-4
PDZ 通过 syndecan-4 介导的信号传导
基本信息
- 批准号:6545320
- 负责人:
- 金额:$ 26.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-08-01 至 2006-07-31
- 项目状态:已结题
- 来源:
- 关键词:binding proteins biological signal transduction fibroblast growth factor gene targeting genetically modified animals heparan sulfate laboratory mouse myocardial infarction phosphatidylinositols protein binding protein protein interaction syndecan transcription factor vascular endothelium yeast two hybrid system
项目摘要
The interaction between the carboxy terminus of transmembrane receptors with the conserved PDZ binding module of adaptor proteins has emerged as a major mechanism of organizing signal-transduction protein complexes. The syndecan family of transmembrane proteoglycans belongs to this large group of PDZ- binding cell surface receptors. Until recently, the generally held concept of proteoglycan functions was centered on their heparan sulfate chains as the active component involved in binding of growth factors and of extracellular matrix proteins. This view is undergoing a revision, however, as a consequence of newly emerging findings, which suggest that the highly conserved cytoplasmic tails of the syndecan family of transmembrane proteoglycans also participate in the transduction of outside-in signals. While all the syndecans possess a PDZ-binding carboxy- terminus, the widely expressed syndecan-4 contains a unique phosphatidylinositol 4,5-bisphosphate binding domain in its cytoplasmic tail, and facilitates the activation of protein kinase C alpha. Recent findings from our laboratory indicate that the interaction between the cytoplasmic tail of syndecan-4 and PDZ domain-containing protein(s) is essential for the cellular response to basic fibroblast growth factor, as demonstrated by the impairment of migration, of proliferation, and of vascular network formation by endothelial cells upon the disruption of this interaction. The objective of this proposal is to elucidate the nature of the signaling mechanism through the PDZ-syndecan-4 interaction, employing the recently identified syndecan-4 PDZ partner synectin as a prototype. This interaction is part of a novel FGF signaling pathway, and forms a new paradigm for the regulation of signal transduction. We will focus on (1) characterizing the binding mechanism between syndecan-4 and synectin, (2) identifying additional synectin binding partners other than syndecan-4, in order to determine further downstream members of the syndecan-4-mediated signaling pathway, and (3) characterize the functions of synectin in general, and the endothelial cell-specific ones in particular, by a synectin gene knockout mouse model.
跨膜受体的羧基末端与接头蛋白的保守PDZ结合模块之间的相互作用已成为组织信号转导蛋白复合物的主要机制。 跨膜蛋白多糖的多配体家族属于这一大类PDZ结合细胞表面受体。 直到最近,蛋白多糖功能的普遍概念仍集中在其硫酸乙酰肝素链上,作为参与生长因子和细胞外基质蛋白结合的活性成分。然而,由于新发现的结果,这种观点正在被修正,这些新发现表明跨膜蛋白聚糖的多配体家族高度保守的细胞质尾部也参与了由外向内信号的转导。 虽然所有多配体都具有 PDZ 结合羧基末端,但广泛表达的多配体-4 在其胞质尾部含有独特的磷脂酰肌醇 4,5-二磷酸结合结构域,并促进蛋白激酶 C α 的激活。 我们实验室的最新研究结果表明,syndecan-4 的细胞质尾部和含有 PDZ 结构域的蛋白质之间的相互作用对于细胞对碱性成纤维细胞生长因子的反应至关重要,这一点通过迁移、增殖和细胞迁移受损来证明。当这种相互作用被破坏时,内皮细胞形成血管网络。 该提案的目的是利用最近鉴定的 syndecan-4 PDZ 伙伴 Synectin 作为原型,阐明通过 PDZ-syndecan-4 相互作用的信号传导机制的性质。 这种相互作用是新型 FGF 信号通路的一部分,并形成信号转导调节的新范例。 我们将重点关注 (1) 表征 syndecan-4 和 synectin 之间的结合机制,(2) 识别 syndecan-4 以外的其他 synectin 结合伴侣,以确定 syndecan-4 介导的信号通路的进一步下游成员,以及(3) 通过 Synectin 基因敲除小鼠模型,表征 Synectin 的一般功能,特别是内皮细胞特异性功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Arie Horowitz其他文献
Arie Horowitz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Arie Horowitz', 18)}}的其他基金
Regulation of endothelial cell junctions by VEGF and angiopoietin
VEGF 和血管生成素对内皮细胞连接的调节
- 批准号:
9225233 - 财政年份:2014
- 资助金额:
$ 26.58万 - 项目类别:
Regulation of endothelial cell junctions by VEGF and angiopoietin
VEGF 和血管生成素对内皮细胞连接的调节
- 批准号:
8694252 - 财政年份:2014
- 资助金额:
$ 26.58万 - 项目类别:
Regulation of endothelial cell junctions by VEGF and angiopoietin
VEGF 和血管生成素对内皮细胞连接的调节
- 批准号:
8827843 - 财政年份:2014
- 资助金额:
$ 26.58万 - 项目类别:
PDZ-mediated signaling through syndecan-4
PDZ 通过 syndecan-4 介导的信号传导
- 批准号:
6612585 - 财政年份:2002
- 资助金额:
$ 26.58万 - 项目类别:
PDZ-mediated signaling through syndecan-4
PDZ 通过 syndecan-4 介导的信号传导
- 批准号:
6930468 - 财政年份:2002
- 资助金额:
$ 26.58万 - 项目类别:
PDZ-mediated signaling through syndecan-4
PDZ 通过 syndecan-4 介导的信号传导
- 批准号:
6787673 - 财政年份:2002
- 资助金额:
$ 26.58万 - 项目类别:
相似国自然基金
生物钟核心转录因子PRRs调控JA信号转导及植物对灰霉菌防御的分子机理
- 批准号:32370606
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
硫化氢抑制采后枸杞乙烯生物合成及其信号转导的机理研究
- 批准号:32360612
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
基于“丛枝菌根真菌-激素信号转导-转录因子-L/ODC基因”调控路径解析苦参生物碱生物合成的调控机制
- 批准号:82304678
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
水稻中葡萄糖-TOR-EIN2信号转导的生物学功能研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
钙网蛋白“反转位”介导的力—生物学信号转导在低负荷压应力促进髓核自修复中的作用及机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Characterization of the Regulation and Gene Targets of TBX2 in Rhabdomyosarcoma
横纹肌肉瘤中 TBX2 的调控和基因靶点的表征
- 批准号:
10731025 - 财政年份:2023
- 资助金额:
$ 26.58万 - 项目类别:
Identification of a new role of membrane‐type 1 matrix metalloproteinases in corneal neovascularization
膜 1 型基质金属蛋白酶在角膜新生血管形成中的新作用的鉴定
- 批准号:
10585794 - 财政年份:2023
- 资助金额:
$ 26.58万 - 项目类别:
Role of FGF23 peptides in chronic kidney disease (CKD)
FGF23 肽在慢性肾脏病 (CKD) 中的作用
- 批准号:
10586788 - 财政年份:2023
- 资助金额:
$ 26.58万 - 项目类别:
Cell membrane-targeting proteoglycan chimeras as selective growth factor signaling actuators
作为选择性生长因子信号传导执行器的细胞膜靶向蛋白聚糖嵌合体
- 批准号:
10588085 - 财政年份:2023
- 资助金额:
$ 26.58万 - 项目类别:
Novel regulation of insulin action in the liver
肝脏中胰岛素作用的新调节
- 批准号:
10549322 - 财政年份:2022
- 资助金额:
$ 26.58万 - 项目类别: